Flu vaccine showdown: 2023 vs 2024 formula tested in small study
NCT ID NCT06567860
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the 2023 and 2024 flu vaccines protect against influenza A. Researchers gave the 2023 vaccine to 23 healthy adults between May and June 2024, when the vaccine was about to expire, to compare their immune responses with people who got the 2023 vaccine earlier or the 2024 vaccine later. The goal was to understand how updating the vaccine each year affects protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
La Jolla Institute for Immunology
La Jolla, California, 92037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New rapid test could spot COVID and flu in minutes
- New rapid test could spot flu and RSV in minutes at your local clinic
- New swab test aims to spot COVID, flu, and RSV in minutes
- New device aims to detect flu, RSV, and COVID-19 in one quick test
- Rapid COVID and flu tests put to the test in real clinics
- New At-Home test could detect flu and COVID in minutes